The U.S. Food and Drug Administration (FDA) has issued an urgent public safety alert after receiving multiple reports of illnesses related to Diamond Shruumz Brand Microdosing Chocolate Bars, Infused Cones and Micro and Macro Dose Gummies.

FDA is urging retailers to stop selling the products while the investigation is ongoing. FDA has been in contact with the firm about a possible voluntary recall, but to date, the firm has not initiated the recall.

Diamond Shruumz-brand products can be purchased online and in person at a variety of retail locations nationwide including smoke/vape shops, and at retailers that sell hemp-derived products such as cannabidiol (CBD) or delta-8 tetrahydrocannabinol (delta-8 THC). The full list of retailers is currently unknown.

Reports indicated a variety of severe symptoms including seizures, central nervous system depression (loss of consciousness, confusion, sleepiness), agitation, abnormal heart rates, hyper/hypotension, nausea and vomiting. So far, 39 illnesses have been reported across almost 20 states, 23 of which required hospitalization.

As of June 25, lab testing by the FDA found that the Diamond Shruumz Dark Chocolate Bar contains 4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin), desmethoxyyangonin, dihydrokavain and kavain and the Diamond Shruumz Birthday Cake Chocolate Bar contains 4-acetoxy-N,N-dimethyltryptamine (4-acetoxy-DMT, also known as O-acetylpsilocin or psilacetin).

FDA and CDC, in collaboration with America’s Poison Centers and state and local partners, continue to investigate. The two organizations encourage consumers and retailers to report adverse effects to FDA's MedWatch Safety Information and Adverse Event Reporting Program.